Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Differential tumor infiltration by T-cells characterizes intrinsic molecular subtypes in breast cancer
M. Miyan, J Schmidt-Mende, Rolf Kiessling, et al.
Journal of Translational Medicine (2016) Vol. 14, Iss. 1
Open Access | Times Cited: 68

Showing 1-25 of 68 citing articles:

Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response
Peng Jiang, Shengqing Gu, Deng Pan, et al.
Nature Medicine (2018) Vol. 24, Iss. 10, pp. 1550-1558
Open Access | Times Cited: 3896
Immune Checkpoint Inhibitors in Triple Negative Breast Cancer Treatment: Promising Future Prospects
Remy Thomas, Ghaneya Al‐Khadairi, Julie Decock
Frontiers in Oncology (2021) Vol. 10
Open Access | Times Cited: 130
CECR2 drives breast cancer metastasis by promoting NF-κB signaling and macrophage-mediated immune suppression
Meiling Zhang, Zongzhi Liu, Keisuke Aoshima, et al.
Science Translational Medicine (2022) Vol. 14, Iss. 630
Open Access | Times Cited: 91
Role of tumor microenvironment in triple-negative breast cancer and its prognostic significance
Tian‐Jian Yu, Gen‐Hong Di
Chinese Journal of Cancer Research (2017) Vol. 29, Iss. 3, pp. 237-252
Open Access | Times Cited: 146
Breast cancer genomics and immuno-oncological markers to guide immune therapies
Dora Hammerl, Marcel Smid, A. Mieke Timmermans, et al.
Seminars in Cancer Biology (2017) Vol. 52, pp. 178-188
Open Access | Times Cited: 136
Tumor infiltrating lymphocytes in early breast cancer
Giancarlo Pruneri, Andrea Vingiani, Carsten Denkert
The Breast (2017) Vol. 37, pp. 207-214
Closed Access | Times Cited: 134
The balance between breast cancer and the immune system: Challenges for prognosis and clinical benefit from immunotherapies
Constantin N. Baxevanis, Sotirios P. Fortis, Sonia A. Perez
Seminars in Cancer Biology (2019) Vol. 72, pp. 76-89
Closed Access | Times Cited: 118
Resident memory CD8+ T cells within cancer islands mediate survival in breast cancer patients
Colt A. Egelston, Christian Avalos, Travis Y. Tu, et al.
JCI Insight (2019) Vol. 4, Iss. 19
Open Access | Times Cited: 99
CARM1 Inhibition Enables Immunotherapy of Resistant Tumors by Dual Action on Tumor Cells and T Cells
Sushil Kumar, Zexian Zeng, Archis Bagati, et al.
Cancer Discovery (2021) Vol. 11, Iss. 8, pp. 2050-2071
Open Access | Times Cited: 73
Early-Stage Luminal B-Like Breast Cancer Exhibits a More Immunosuppressive Tumor Microenvironment than Luminal A-Like Breast Cancer
Tânia Moura, Olga Caramelo, Isabel Silva, et al.
Biomolecules (2025) Vol. 15, Iss. 1, pp. 78-78
Open Access | Times Cited: 1
Differential intratumoral distributions of CD8 and CD163 immune cells as prognostic biomarkers in breast cancer
Sotirios P. Fortis, Michael Sofopoulos, Nectaria N. Sotiriadou, et al.
Journal for ImmunoTherapy of Cancer (2017) Vol. 5, Iss. 1
Open Access | Times Cited: 75
Recent Discoveries of Macromolecule- and Cell-Based Biomarkers and Therapeutic Implications in Breast Cancer
Hsing‐Ju Wu, Pei‐Yi Chu
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 2, pp. 636-636
Open Access | Times Cited: 47
T cell receptor sequencing of early-stage breast cancer tumors identifies altered clonal structure of the T cell repertoire
John F. Beausang, Aaron R. Wheeler, Natalie H. Chan, et al.
Proceedings of the National Academy of Sciences (2017) Vol. 114, Iss. 48
Open Access | Times Cited: 60
CCR2 Chemokine Receptors Enhance Growth and Cell-Cycle Progression of Breast Cancer Cells through SRC and PKC Activation
Min Yao, Wei Bin Fang, Curtis Smart, et al.
Molecular Cancer Research (2018) Vol. 17, Iss. 2, pp. 604-617
Open Access | Times Cited: 57
Discovering lncRNA mediated sponge interactions in breast cancer molecular subtypes
Gülden Olgun, Özgür Şahin, Öznur Taştan
BMC Genomics (2018) Vol. 19, Iss. 1
Open Access | Times Cited: 50
The role of immune infiltrates as prognostic biomarkers in patients with breast cancer
Constantin N. Baxevanis, Michael Sofopoulos, Sotirios P. Fortis, et al.
Cancer Immunology Immunotherapy (2019) Vol. 68, Iss. 10, pp. 1671-1680
Open Access | Times Cited: 49
Novel miRNA Targets and Therapies in the Triple-Negative Breast Cancer Microenvironment: An Emerging Hope for a Challenging Disease
Amal Qattan
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 23, pp. 8905-8905
Open Access | Times Cited: 45
Lymphovascular invasion in breast cancer is associated with gene expression signatures of cell proliferation but not lymphangiogenesis or immune response
Mariko Asaoka, Santosh K. Patnaik, Lei Zhang, et al.
Breast Cancer Research and Treatment (2020) Vol. 181, Iss. 2, pp. 309-322
Open Access | Times Cited: 44
Tumor-Infiltrating Lymphocytes (TILs) in Early Breast Cancer Patients: High CD3+, CD8+, and Immunoscore Are Associated with a Pathological Complete Response
Bernardo L. Rapoport, Simon Nayler, Bernhard Mlecnik, et al.
Cancers (2022) Vol. 14, Iss. 10, pp. 2525-2525
Open Access | Times Cited: 27
The Emerging Role of Immune Cells and Targeted Therapeutic Strategies in Diabetic Wounds Healing
Jianying Song, Li‐Xin Hu, Bo Liu, et al.
Journal of Inflammation Research (2022) Vol. Volume 15, pp. 4119-4138
Open Access | Times Cited: 24
Systemic and local immunosuppression in patients with high-grade meningiomas
Yuping D. Li, Dorina Veliceasa, Jason Lamano, et al.
Cancer Immunology Immunotherapy (2019) Vol. 68, Iss. 6, pp. 999-1009
Open Access | Times Cited: 42
The composition of T cell infiltrates varies in primary invasive breast cancer of different molecular subtypes as well as according to tumor size and nodal status
Anna Glajcar, Joanna Szpor, Diana Hodorowicz‐Zaniewska, et al.
Virchows Archiv (2019) Vol. 475, Iss. 1, pp. 13-23
Open Access | Times Cited: 40
A high CD8 to FOXP3 ratio in the tumor stroma and expression of PTEN in tumor cells are associated with improved survival in non-metastatic triple-negative breast carcinoma
Monique Celeste Tavares, Cristina Sampaio, Geraldine Eltz Lima, et al.
BMC Cancer (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 28
CD73-Mediated Immunosuppression Is Linked to a Specific Fibroblast Population That Paves the Way for New Therapy in Breast Cancer
Ilaria Magagna, Nicolas Gourdin, Yann Kieffer, et al.
Cancers (2021) Vol. 13, Iss. 23, pp. 5878-5878
Open Access | Times Cited: 28
Anti‐tumor effects of miR‐34a by regulating immune cells in the tumor microenvironment
Man Yin, Zhiqiang Zhang, Yunfei Wang
Cancer Medicine (2023) Vol. 12, Iss. 10, pp. 11602-11610
Open Access | Times Cited: 12
Page 1 - Next Page

Scroll to top